FST-100 in the Treatment of Acute Viral Conjunctivitis
Status:
Completed
Trial end date:
2014-03-10
Target enrollment:
Participant gender:
Summary
This randomized, double masked, multi-center study is being conducted to support the safety
and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to
show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution
of acute viral conjunctivitis.